Lipid-coated mesoporous silica nanoparticles for anti-viral applications via delivery of CRISPR-Cas9 ribonucleoproteins

Abstract Emerging and re-emerging viral pathogens present a unique challenge for anti-viral therapeutic development. Anti-viral approaches with high flexibility and rapid production times are essential for combating these high-pandemic risk viruses. CRISPR-Cas technologies have been extensively repu...

Full description

Bibliographic Details
Main Authors: Annette E. LaBauve, Edwin A. Saada, Iris K. A. Jones, Richard Mosesso, Achraf Noureddine, Jessica Techel, Andrew Gomez, Nicole Collette, Michael B. Sherman, Rita E. Serda, Kimberly S. Butler, C. Jeffery Brinker, Joseph S. Schoeniger, Darryl Sasaki, Oscar A. Negrete
Format: Article
Language:English
Published: Nature Portfolio 2023-04-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-33092-4